|
ICOPE Program Feasibility in the Management of Myeloma Patients
RECRUITINGN/ASponsored by University Hospital, Toulouse
Actively Recruiting
PhaseN/A
SponsorUniversity Hospital, Toulouse
Started2025-12-03
Est. completion2026-12-03
Eligibility
Age70 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06247189
Summary
This project proposes to adapt monthly the existing ICOPE (Integrated Care for Older People) MONITOR program for elderly myeloma patients. This adaptation aims to detect earlier functional decline and prevent loss of autonomy.
Eligibility
Age: 70 Years+Healthy volunteers accepted
Inclusion Criteria: * Male or female aged over 70 years, * Patient with multiple myeloma * WHO performance status 0-3, * Patient eligible for first- or second-line treatment * Patient willing to participate in ICOPE MONITOR program * Patient or caregiver able to use digital tools of ICOPE MONITOR: application or chatbot (computer or tablet or smartphone) * Patient with a life expectancy of more than 3 months, * Patient or caregiver able to understand, read and speak French * Person affiliated or benefiting from a social security. * Free, informed and written consent signed by the participant and the investigator (at the latest on the day of inclusion and before any examination required by the research) Exclusion Criteria: * Patient in palliative care * Patient participating in a study evaluating another frailty prevention program * Patient unable to understand the study * Patient under court protection, guardianship or curatorship, * Patient refusal.
Conditions3
CancerFrailtyMultiple Myeloma
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorUniversity Hospital, Toulouse
Started2025-12-03
Est. completion2026-12-03
Eligibility
Age70 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06247189